Pemetrexed Disodium and Gemcitabine in Treating Patients With Advanced Cancer of the Urothelium
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert Dreicer, MD, FACP
The Cleveland Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
121 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Aurora Presbyterian Hospital
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital
Colorado Springs, Colorado, United States
- Ccop - Colorado Cancer Research Program, Incorporated
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - St. Luke'S Medical Center
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- St. Joseph Hospital
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Hope Cancer Care Center at Longmont United Hospital
Longmont, Colorado, United States
- St. Mary-Corwin Regional Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Yale Comprehensive Cancer Center at Yale University School of Medicine
New Haven, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Ccop - Christiana Care Health Services
Newark, Delaware, United States
- St. Francis Hospital
Wilmington, Delaware, United States
- Baptist Cancer Institute - Jacksonville
Jacksonville, Florida, United States
- Watson Clinic, Llc
Lakeland, Florida, United States
- Hematology and Oncology of Northeast Georgia
Athens, Georgia, United States
- Mbccop-Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Hinsdale Hematology Oncology Associates
Hinsdale, Illinois, United States
- Joliet Oncology Hematology Associates, Limited - West
Joliet, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- Ccop - Carle Cancer Center
Urbana, Illinois, United States
- Carle Cancer Center at Carle Foundation Hospital
Urbana, Illinois, United States
- Elkhart General Hospital
Elkhart, Indiana, United States
- Center for Cancer Therapy at Laporte Hospital and Health Services
La Porte, Indiana, United States
- Saint Anthony Memorial Health Centers
Michigan City, Indiana, United States
- Saint Joseph Regional Medical Center - Plymouth Campus
Plymouth, Indiana, United States
- Ccop - Northern Indiana Cr Consortium
South Bend, Indiana, United States
- Memorial Hospital of South Bend
South Bend, Indiana, United States
- Mcfarland Clinic, P.C.
Ames, Iowa, United States
- Mercy Medical Center - Sioux City
Sioux City, Iowa, United States
- Siouxland Hematology-Oncology Associates
Sioux City, Iowa, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- St. Luke'S Regional Medical Center
Sioux City, Iowa, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Aug 2004
- Primary completion
- 30 Sept 2007
- Completion
- 31 May 2009
- Last update posted
- 22 Jun 2023
- Registered enrollment
- 46
- Registry id
- NCT00053209
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.